Paper Details

  1. Home
  2. Paper Details

Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C.

Author: AlbertiA, BernardinelloE, BonettiP, CasarinP, CavallettoL, ChemelloL, DonadaC, PontissoP, UrbanF

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study examines the effectiveness of retreatment with interferon (IFN) alone in patients with chronic hepatitis C infection who did not respond to initial IFN treatment. The study aims to determine if IFN retreatment can be beneficial for these patients, given that a majority (75-85%) do not respond to initial IFN therapy.
Paper Details　
Original Abstract of the Article :
Approximately 75%-85% of patients with chronic hepatitis C virus (HCV) infection do not have a sustained response when treated with interferon (IFN). Limited information exists on the efficacy of retreatment with IFN alone in these patients. The aim of this study was to define the efficacy of IFN re...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1053/gast.1997.v113.pm9352869

データ提供：米国国立医学図書館（NLM）

Interferon Therapy for Chronic Hepatitis C: Navigating the Shifting Sands

Chronic hepatitis C infection presents a formidable challenge, akin to navigating a vast desert. This study explores the efficacy of interferon therapy, a common treatment for chronic hepatitis C, in patients who have not responded to a first course of treatment. The researchers investigated the effectiveness of retreatment with interferon alone in these patients, aiming to understand the potential benefits and limitations of this approach.

Retreatment with Interferon: A Second Attempt in the Fight Against Hepatitis C

The study found that retreatment with interferon alone yielded a limited response in patients who had not responded to a first course of therapy. While the study provided valuable data on the efficacy of retreatment, it also highlighted the need for alternative therapies and innovative approaches to manage persistent hepatitis C infection. The researchers emphasized the importance of ongoing research to develop more effective treatment options for these challenging cases.

Finding New Pathways in Hepatitis C Treatment

This study underscores the complexity of managing chronic hepatitis C infection. The findings highlight the need for ongoing research to develop novel therapeutic strategies that can effectively target this persistent viral infection. The researchers' call for continued investigation into alternative therapies is crucial for improving the lives of patients with chronic hepatitis C.

Dr.Camel's Conclusion

This study serves as a reminder that even in the vast desert of medical research, we must constantly seek new oases of hope for patients. While retreatment with interferon alone may not be the ultimate solution for all patients with persistent hepatitis C, it emphasizes the need for continued research and the development of innovative therapies to combat this challenging viral infection.

Date :
  1. Date Completed 1997-11-13
  2. Date Revised 2019-07-07
Further Info :

Pubmed ID

9352869

DOI: Digital Object Identifier

10.1053/gast.1997.v113.pm9352869

Related Literature

Article Analysis
・Effective treatment of hepatitis c
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.